ATE555385T1 - N1,n12-diacetylspermin als tumormarker - Google Patents

N1,n12-diacetylspermin als tumormarker

Info

Publication number
ATE555385T1
ATE555385T1 AT04719642T AT04719642T ATE555385T1 AT E555385 T1 ATE555385 T1 AT E555385T1 AT 04719642 T AT04719642 T AT 04719642T AT 04719642 T AT04719642 T AT 04719642T AT E555385 T1 ATE555385 T1 AT E555385T1
Authority
AT
Austria
Prior art keywords
diacetylspermine
tumor marker
tumor
evaluating
state
Prior art date
Application number
AT04719642T
Other languages
English (en)
Inventor
Masao Kawakita
Kyoko Hiramatsu
Keiichi Takahashi
Naotaka Hamasaki
Kouji Yamaguchi
Tsunehisa Kaku
Kouichiro Muta
Munechika Enjoji
Seiji Naito
Jun Hayashi
Shoshu Mitsuyama
Hiroyuki Yamashita
Tohru Inoue
Masato Kato
Original Assignee
Crc Inc
Tokyo Metropolitan Inst Medical Science
Tokyo Metropolitan Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crc Inc, Tokyo Metropolitan Inst Medical Science, Tokyo Metropolitan Government filed Critical Crc Inc
Application granted granted Critical
Publication of ATE555385T1 publication Critical patent/ATE555385T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04719642T 2003-03-11 2004-03-11 N1,n12-diacetylspermin als tumormarker ATE555385T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003065562 2003-03-11
JP2003367568 2003-10-28
PCT/JP2004/003211 WO2004081569A1 (ja) 2003-03-11 2004-03-11 腫瘍マーカーとしてのｎ１，ｎ１２－ジアセチルスペルミン

Publications (1)

Publication Number Publication Date
ATE555385T1 true ATE555385T1 (de) 2012-05-15

Family

ID=32992951

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04719642T ATE555385T1 (de) 2003-03-11 2004-03-11 N1,n12-diacetylspermin als tumormarker

Country Status (5)

Country Link
US (2) US20070161059A1 (de)
EP (1) EP1610127B1 (de)
JP (2) JP4608432B2 (de)
AT (1) ATE555385T1 (de)
WO (1) WO2004081569A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687231B2 (en) * 2006-01-30 2010-03-30 Yamasa Corporation Method for determining degree of negative effect of macrophages on vertebrate
JP4678785B2 (ja) * 2006-01-30 2011-04-27 ヤマサ醤油株式会社 動物へのマクロファージの悪影響の度合いを検出する方法
WO2007148451A1 (ja) * 2006-06-22 2007-12-27 Kikkoman Corporation ポリアミンオキシダーゼの安定化方法と基質特異性の改良方法
JP4947725B2 (ja) * 2008-03-28 2012-06-06 ヤマサ醤油株式会社 ジアセチルポリアミンの分解防止法
WO2011136343A1 (ja) * 2010-04-28 2011-11-03 財団法人東京都医学総合研究所 がんの検出方法
WO2011143779A1 (en) 2010-05-21 2011-11-24 The Governors Of The University Of Alberta Methods for the assessment of colorectal cancer and colorectal polyps by measurement of metabolites in urine
CN104678003A (zh) * 2013-11-29 2015-06-03 沈阳药科大学 尿液用于评估肝癌症疾病的生物标记物
JP7038044B2 (ja) * 2015-06-26 2022-03-17 バイオマーク キャンサー システムズ インコーポレイテッド 肺癌を検出するためのバイオマーカーパネル
CN105527434B (zh) * 2015-12-31 2017-12-19 辽宁迈迪生物科技有限公司 一种用于二乙酰精胺(das)检测的试剂盒
CN108226483B (zh) * 2018-01-19 2020-06-26 辽宁迈迪生物科技股份有限公司 一种das检测试剂盒及其制备方法和应用
CN109651503A (zh) * 2018-11-28 2019-04-19 天津国际生物医药联合研究院 一种人工抗原的制备方法及应用
US11840720B2 (en) 2019-12-23 2023-12-12 Metabolomic Technologies Inc. Urinary metabolomic biomarkers for detecting colorectal cancer and polyps
JP2023545017A (ja) * 2020-10-02 2023-10-26 ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム 肺がんの検出及び治療のための方法
KR20230113742A (ko) * 2020-10-29 2023-08-01 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 난소암의 검출 및 치료를 위한 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4663831B2 (ja) * 1997-07-09 2011-04-06 日本化薬株式会社 モノクローナル抗体、細胞株及びｎ１，ｎ１２−ジアセチルスペルミンの測定法
US6673914B1 (en) * 1998-01-22 2004-01-06 John Wayne Cancer Institute Human tumor-associated gene
US6355623B2 (en) * 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage

Also Published As

Publication number Publication date
JP5586368B2 (ja) 2014-09-10
US20090298098A1 (en) 2009-12-03
JP4608432B2 (ja) 2011-01-12
JPWO2004081569A1 (ja) 2006-06-15
US9134313B2 (en) 2015-09-15
JP2011027742A (ja) 2011-02-10
WO2004081569A1 (ja) 2004-09-23
EP1610127A4 (de) 2006-06-14
US20070161059A1 (en) 2007-07-12
EP1610127A1 (de) 2005-12-28
EP1610127B1 (de) 2012-04-25

Similar Documents

Publication Publication Date Title
DK2275815T3 (da) Forbedrede immunoassay-fremgangsmåder
ATE555385T1 (de) N1,n12-diacetylspermin als tumormarker
WO2007002579A3 (en) Assay cartridges and methods for point of care instruments
PT1322960E (pt) Ensaio de micro-arranjos de alergenios
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
DE602006018578D1 (de) Diagnose- und prognoseverfahren von blasenkrebs.
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2005103698A3 (en) Methods and antibodies for nitrofuran detection
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
WO2002099381A3 (en) A single-cell biosensor for the measurement of gpcr ligands in a test sample
EP2012116A4 (de) Verfahren und vorrichtung zur individuellen unterscheidung
ITMI20051057A1 (it) Dispositivo di prelievo, raccolta e trasporto di campioni biologici
FR2895087B1 (fr) Methode de discrimination d'au moins deux populations cellulaires et application
DE602007011886D1 (de) Diagnostisches Verfahren zum Nachweis von Helicobacter pylori
DE60225168D1 (de) Verfahren zur auswahl bioaktiver wirkstoffe durch lumineszenzkopplung und lebendes zellensystem dafür
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales
FR2868071B1 (fr) Reactifs de marquage, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques
WO2004085669A3 (en) Identification and quantification of microbial species in a sample
GB0304832D0 (en) Assay method
ATE274702T1 (de) Verwendung derivatisierter reagenzien in chemilumineszenz- und elektrochemilumineszenz- nachweisverfahren
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
ATE491158T1 (de) Mehrfachmarkierung für den nachweis von analyten
CY1117148T1 (el) Βελτιωμενες μεθοδοι ανοσοπροσδιορισμου